Prime Minister Modi celebrated India's space achievements during his 'Mann Ki Baat' address, highlighting ISRO's 100th rocket launch and other milestones. He also announced that inspiring women ...

During FY25 (Until October 2024), India’s merchandise exports reached US$ 252.28 billion, up from US$ 244.51 billion in the previous fiscal. *By 2030, Indian middle class is expected to have the ...

PM Ramgoolam Shivraj Singh Chouhan complains of ‘broken seat’ on Air India flight: ‘Isn’t this cheating passengers?’ Crackdown to transport convoys: A new security plan for Manipur Amid US-Russia ...

The Indian healthcare market, which was valued at US$ 110 billion in 2016 is now projected to reach US$ 638 billion by 2025. * The healthcare sector, as of 2024, is one of India’s largest employers, ...

Tesla has started recruiting in India, hinting at its plans to enter the country’s electric vehicle (EV) market. This follows Tesla CEO Elon Musk and Prime Minister Narendra Modi’s meeting during the ...

QLS-111 effectively lowers IOP by reducing distal outflow resistance and episcleral venous pressure in POAG and OHT patients. The Osprey trial showed the 0.015% concentration of QLS-111 achieved a ...

Mr. Mukesh Ambani is the Managing Director and Chairman of Reliance Industries, and he holds the title of India’s richest person. According to the latest financial reports, Reliance Industries ...

India is in a period of unprecedented opportunity, challenge and ambition in its development. The country’s extreme poverty rate has fallen from 46 percent to 21 percent in the two decades up to 2011, ...

Over the past few weeks, multiple reports have emerged suggesting that Chinese companies are restricting export of vital advanced capital goods and machinery to India. Indian manufacturers of ...

India is keen to expand its manufacturing sector, with a focus on diversifying into newer lines of production, advancing the industrial capacity of traditional sectors like automobiles, and ...

QLS-111 added to latanoprost drove up to 3.6 mmHg greater reduction in IOP as compared to latanoprost alone DEDHAM, Mass.--(BUSINESS WIRE)--Qlaris Bio, Inc., a clinical-stage biotechnology company ...